Skip to content

What is the difference between Oruvail and Orudis?: A Guide to Ketoprofen Formulations

3 min read

Though both Oruvail and Orudis contain the active ingredient ketoprofen, a nonsteroidal anti-inflammatory drug (NSAID), their primary distinction lies in their release mechanisms. Oruvail is an extended-release formulation for long-term management, while Orudis is an immediate-release version for rapid symptom relief. Understanding this fundamental difference is crucial for effective treatment planning.

Quick Summary

Oruvail and Orudis are both brand names for the NSAID ketoprofen, but they have different delivery systems. Orudis provides immediate relief for acute pain, whereas Oruvail is an extended-release formula designed for consistent, long-term treatment of chronic conditions.

Key Points

  • Active Ingredient: Both Oruvail and Orudis contain ketoprofen, an NSAID, for treating pain and inflammation.

  • Release Profile: The key difference is the drug delivery system; Orudis is immediate-release, while Oruvail is extended-release.

  • Onset of Action: Orudis provides rapid relief (0.5-2 hours to peak), whereas Oruvail offers delayed, sustained action (6-7 hours to peak).

  • Suitable Uses: Orudis is for acute pain and short-term conditions, while Oruvail is for the long-term management of chronic issues like arthritis.

  • Dosing Schedule: The dosing frequency differs significantly; Orudis is taken multiple times daily, while Oruvail is a once-daily formulation.

  • Brand Name Status: The original Orudis and Oruvail brand names are no longer available in the U.S., but generic ketoprofen is produced in both immediate-release and extended-release forms.

In This Article

What are Orudis and Oruvail?

Orudis and Oruvail are different brand-name medications containing the same active ingredient, ketoprofen. Ketoprofen is a nonsteroidal anti-inflammatory drug (NSAID) that helps reduce pain, inflammation, and fever by inhibiting prostaglandins, substances in the body that cause these responses. The key difference between Orudis and Oruvail lies in their release mechanisms, which affects how quickly the medication works and how often it needs to be taken.

The core difference: Immediate vs. Extended Release

Ketoprofen's release into the body is the main difference between Orudis and Oruvail, impacting their speed of action and appropriate uses.

Orudis (Immediate-Release) Orudis capsules release ketoprofen rapidly in the stomach, leading to quick absorption and a fast onset of action, with peak levels typically within 0.5 to 2 hours. It is usually taken every 6 to 8 hours for acute, or short-term, pain like menstrual cramps or post-operative discomfort. Orudis can also be used for symptoms of rheumatoid arthritis and osteoarthritis.

Oruvail (Extended-Release) Oruvail contains coated pellets of ketoprofen that are designed to dissolve slowly in the small intestine, providing a controlled and slower release. This results in a more gradual onset of relief, with peak levels reached around 6 to 7 hours after dosing. Oruvail's extended-release allows for once-daily dosing, making it suitable for long-term management of chronic conditions such as rheumatoid arthritis and osteoarthritis. It is not intended for acute pain needing immediate relief.

Comparing Oruvail and Orudis

Feature Orudis (Immediate-Release) Oruvail (Extended-Release)
Release Profile Rapidly dissolves in the stomach. Coated pellets dissolve slowly in the small intestine.
Onset of Action Fast (Peak plasma levels in 0.5-2 hours). Delayed (Peak plasma levels in 6-7 hours).
Best For... Acute pain and conditions requiring immediate relief, such as menstrual cramps and immediate post-operative pain. Chronic conditions requiring consistent, long-term management, such as osteoarthritis and rheumatoid arthritis.
Dosing Frequency Multiple times per day (e.g., every 6-8 hours). Once daily.
Mechanism Standard, immediate-acting NSAID. Sustained-release delivery system.

Clinical considerations and practical implications

The choice between Orudis and Oruvail depends on the type of pain and the treatment goals. For sudden, intense pain, the rapid action of Orudis is beneficial, while Oruvail's sustained release is better for ongoing chronic pain. Healthcare providers consider a patient's medical history, especially any gastrointestinal issues, as NSAIDs can cause stomach upset. Taking these medications with food, milk, or antacids can help minimize side effects. Although the brand names Orudis and Oruvail may no longer be available in the U.S., generic ketoprofen is still produced in both immediate and extended-release forms.

Conclusion

In conclusion, while Orudis and Oruvail both contain ketoprofen, their differing release mechanisms define their uses. Orudis is immediate-release for acute pain, and Oruvail is extended-release for chronic pain management. This difference in how the drug is delivered allows healthcare providers to choose the most appropriate formulation based on the patient's specific needs for either quick relief or sustained symptom control.

Disclaimer: Always consult with a healthcare professional before making any decisions about your medication. This information is for educational purposes only and should not be used as a substitute for professional medical advice. For authoritative drug information, refer to official sources like the U.S. National Library of Medicine's MedlinePlus.

Frequently Asked Questions

Ketoprofen is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain, inflammation, and fever.

Orudis (or immediate-release ketoprofen) is better for acute pain because it releases the medication quickly, providing faster relief.

Oruvail (or extended-release ketoprofen) is better for chronic pain because its sustained-release action provides consistent, long-lasting relief with once-daily dosing.

It is not recommended to switch between the two formulations or take them together without a doctor's supervision due to their different release profiles and dosing requirements. Always consult your healthcare provider.

The brand names Orudis and Oruvail are no longer marketed in the U.S., but the active ingredient, ketoprofen, is widely available generically in both immediate-release and extended-release versions.

Since they share the same active ingredient, the side effect profile is similar for both. Common side effects include gastrointestinal upset, and there is a risk of serious events like gastrointestinal bleeding and cardiovascular issues with all NSAIDs.

Orudis is typically taken multiple times a day (e.g., every 6 to 8 hours), while Oruvail is a once-daily medication.

Both formulations of ketoprofen can cause stomach upset. Taking them with food, milk, or antacids can help minimize this side effect.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.